{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-21-017640","form_type":"8-K","ticker":"INDP","cik":"0001857044","company_name":"Indaptus Therapeutics, Inc.","filed_at":"2021-07-23T23:59:59+00:00","discovered_at":"2026-05-14T18:04:20.174024+00:00","generated_at":"2026-06-30T03:02:46.076584+00:00","sec_items":["5.02","5.03","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Intec Parent appoints board, officers, and amends charter/bylaws","bullets":["Appointed Hila Karah, Anthony Maddaluna, William Hayes, and Dr. Roger Pomerantz as directors; Pomerantz as Chairman.","Jeffrey Meckler continues as director; officers: Meckler CEO, Nir Sassi CFO, Walt Linscott CBO.","Board committees formed: Audit (Hayes chair, Pomerantz, Karah), Compensation (Maddaluna chair, Hayes), Nominating (Pomerantz chair, Maddaluna).","Amended and restated certificate of incorporation and bylaws adopted effective July 23, 2021.","Intec Israel authorized share capital: 17.5M ordinary shares, 7,370,883 outstanding (as of July 23, 2021)."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-21-017640","json":"https://secwatch.observer/filing/0001493152-21-017640.json","markdown":"https://secwatch.observer/filing/0001493152-21-017640.md","text":"https://secwatch.observer/filing/0001493152-21-017640.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1857044/000149315221017640/0001493152-21-017640-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1857044/000149315221017640/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-30T03:02:46.076584+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"53705716bc","claim":"Dr. Roger J. Pomerantz was appointed as Chairman at Indaptus Therapeutics, Inc..","evidence_excerpt":"Dr. Roger J. Pomerantz also was appointed as Chairman of the Company’s board of directors.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1857044/000149315221017640/0001493152-21-017640-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chairman"}],"fact_type":"executive_change"},{"claim_id":"7c05a49392","claim":"Walt Linscott was appointed as Chief Business Officer at Indaptus Therapeutics, Inc..","evidence_excerpt":"Walt Linscott Chief Business Officer","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1857044/000149315221017640/0001493152-21-017640-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Business Officer"}],"fact_type":"executive_change"},{"claim_id":"8f7dca0c25","claim":"Nir Sassi was appointed as Chief Financial Officer at Indaptus Therapeutics, Inc..","evidence_excerpt":"Nir Sassi Chief Financial Officer","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1857044/000149315221017640/0001493152-21-017640-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"9fdae9b866","claim":"William B. Hayes was appointed as Director at Indaptus Therapeutics, Inc..","evidence_excerpt":"each of Hila Karah, Anthony J. Maddauluna, William B. Hayes and Dr. Roger J. Pomerantz was appointed as a director of Intec Parent, Inc.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1857044/000149315221017640/0001493152-21-017640-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"c8b1780903","claim":"Jeffrey Meckler was appointed as Chief Executive Officer at Indaptus Therapeutics, Inc..","evidence_excerpt":"Jeffrey Meckler Chief Executive Officer","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1857044/000149315221017640/0001493152-21-017640-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"e48ffae06b","claim":"Anthony J. Maddaluna was appointed as Director at Indaptus Therapeutics, Inc..","evidence_excerpt":"each of Hila Karah, Anthony J. Maddauluna, William B. Hayes and Dr. Roger J. Pomerantz was appointed as a director of Intec Parent, Inc.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1857044/000149315221017640/0001493152-21-017640-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"f445d3a04a","claim":"Dr. Roger J. Pomerantz was appointed as Director at Indaptus Therapeutics, Inc..","evidence_excerpt":"each of Hila Karah, Anthony J. Maddauluna, William B. Hayes and Dr. Roger J. Pomerantz was appointed as a director of Intec Parent, Inc.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1857044/000149315221017640/0001493152-21-017640-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"f4535fb2a3","claim":"Hila Karah was appointed as Director at Indaptus Therapeutics, Inc..","evidence_excerpt":"each of Hila Karah, Anthony J. Maddauluna, William B. Hayes and Dr. Roger J. Pomerantz was appointed as a director of Intec Parent, Inc.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1857044/000149315221017640/0001493152-21-017640-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}